QPS (Netherlands)

Recent papers from QPS (Netherlands)

1. Beyond measurement: a strategic perspective on antibody–drug conjugates bioanalysis from the European Bioanalysis ForumBioanalysis · 2026
2. Pharmacokinetics and safety of TBAJ-587, a novel antimycobacterial diarylquinoline, in healthy participantsAntimicrobial Agents and Chemotherapy · 2026
3. New insights into the effects of dissolution profiles on the pharmacokinetics of trientine dihydrochlorideEuropean Journal of Clinical Pharmacology · 2025
4. Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsMovement Disorders · 2025
5. Immune persistence and safety of the AS01 E -adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50–59 years of age, including at-increased-risk adults: A randomized controlled trialHuman Vaccines & Immunotherapeutics · 2025
6. Pilot Clinical Study Showing Abnormal Copper Metabolism in Healthy Wilson Disease Heterozygote SubjectsClinical and Translational Science · 2025
7. Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50–59 Years Compared to ≥60 Years of AgeClinical Infectious Diseases · 2024
8. Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MSJournal of Chromatography B · 2024
9. Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricalsFertility and Sterility · 2023
10. Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial unitsClinical and Translational Science · 2023
11. Development of a pharmacokinetic and pharmacodynamic model for intranasal administration of midazolam in older adults: a single-site two-period crossover studyBritish Journal of Anaesthesia · 2023
12. Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human StudyNeurology and Therapy · 2022
13. The effect of the glucosylceramide synthase inhibitor lucerastat on cardiac repolarization: results from a thorough QT study in healthy subjectsOrphanet Journal of Rare Diseases · 2020
14. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseasesCurrent Opinion in Pulmonary Medicine · 2020
15. Allergen bronchoprovocation test: an important research tool supporting precision medicineCurrent Opinion in Pulmonary Medicine · 2020
16. Modeling the Effect of Excitation on Depth of Anesthesia Monitoring in γ-Aminobutyric Acid Type A Receptor Agonist ABP-700Anesthesiology · 2020
17. Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet AggregationThe Journal of Clinical Pharmacology · 2020
18. Effect of Rifampin‐Mediated OATP1B1 and OATP1B3 Transporter Inhibition on the Pharmacokinetics of the P2Y12 Receptor Antagonist SelatogrelClinical and Translational Science · 2020
19. Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumabmAbs · 2020
20. Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizerEuropean Clinical Respiratory Journal · 2020